Day: July 30, 2020

The Movie Studio Files Application for Registered Trademark with United States Patent and Trademark Office (USPTO)

Written by Customer Service on July 30, 2020. Posted in Public Companies.

FORT LAUDERDALE, Fla., July 30, 2020 (GLOBE NEWSWIRE) — via NetworkWire – The Movie Studio, Inc. (OTC: MVES) (the “Company”) today announces it has submitted an official application to the U.S. Patent and Trademark Office (USPTO) and trademark protection is pending for the Company’s recognizable name, insignia, phrase and logo.

Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO

Written by Customer Service on July 30, 2020. Posted in Public Companies.

THE WOODLANDS, Texas and DEERFIELD, Ill., July 30, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) and TerSera Therapeutics LLC announced today that they have entered into an asset purchase and sale agreement for the sale to TerSera of Lexicon’s rights, title and interest in XERMELO® (telotristat ethyl). Pursuant to the terms of the agreement, TerSera will pay Lexicon approximately $159 million in cash at closing, which includes a $155 million upfront payment and approximately $4 million for existing inventory. Lexicon may receive additional development, regulatory and sales milestone payments of up to an aggregate of $65 million for the development and commercialization of telotristat ethyl in patients with biliary tract cancer. Additionally, Lexicon will be eligible to receive mid-teens royalties on net...

Quinsam Announces Dividend, Intent to Renew Issuer Bid & Update

Written by Customer Service on July 30, 2020. Posted in Public Companies.

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICETORONTO, July 30, 2020 (GLOBE NEWSWIRE) — Quinsam Capital Corporation (CSE: QCA) (“Quinsam” or the “Company”) is pleased to announce its quarterly dividend and the upcoming renewal of its issuer bid. DividendThe Board of Directors of Quinsam has approved the company’s 24th consecutive quarterly dividend. The dividend is $0.00125 per share ($0.005 per share per year). The distribution will be paid on August 26, 2020 to shareholders of record on August 10, 2020. This dividend will be designated as an “eligible dividend” for Canadian income tax purposes. Future quarterly dividends will be subject to Board approval.Issuer Bid UpdateQuinsam announced a normal course issuer bid to purchase...

Endurance International Group Reports 2020 Second Quarter Results and Announces the Acquisition of Retention Science

Written by Customer Service on July 30, 2020. Posted in Public Companies.

GAAP revenue of $274.0 millionNet income of $4.6 millionAdjusted EBITDA of $84.0 millionCash flow from operations of $67.8 millionFree cash flow of $55.9 million Total subscribers on platform were approximately 4.877 million at June 30, 2020BURLINGTON, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Endurance International Group Holdings, Inc. (NASDAQ: EIGI), a leading provider of cloud-based platform solutions designed to help small and medium-sized businesses succeed online, today reported financial results for its second quarter ended June 30, 2020.“Against a backdrop of significant macro-economic disruption due to the COVID-19 pandemic, we are encouraged by the resilience of small businesses and their drive to adapt. As we noted in our preliminary update two weeks ago, we see secular demand for our products and services and are pleased...

uniQure Announces Second Quarter 2020 Financial Results and Highlights Recent Company Progress

Written by Customer Service on July 30, 2020. Posted in Public Companies.

~ Entered into Exclusive Global License Agreement with CSL Behring for Development and Commercialization of uniQure’s Gene Therapy Candidate for Hemophilia B ~~ Completed First Patient Dosing in Phase I/II Clinical Trial of AMT-130 in Huntington’s Disease ~LEXINGTON, Mass. and AMSTERDAM, July 30, 2020 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today reported its financial results for the second quarter of 2020 and highlighted recent progress across its business.“The first half of 2020 has been extremely productive for uniQure with significant achievements across our clinical-stage programs,” stated Matt Kapusta, chief executive officer at uniQure. “The initiation of patient dosing in our Phase I/II study of AMT-130 marked...

Husky Energy Announces Second Quarter 2020 Dividend and Third Quarter 2020 Preferred Shares Dividend Payments

Written by Customer Service on July 30, 2020. Posted in Dividend Reports And Estimates.

CALGARY, Alberta, July 30, 2020 (GLOBE NEWSWIRE) — Husky Energy’s Board of Directors has approved a quarterly dividend of $0.0125 (Cdn) per common share for the three-month period ended June 30, 2020.The dividend will be payable on October 1, 2020 to shareholders of record at the close of business on September 1, 2020.Regular dividend payments on each of the Cumulative Redeemable Preferred Shares – Series 1, Series 2, Series 3,Series 5 and Series 7 – will be paid for the three-month period ended September 30, 2020. The dividends will be payable on September 30, 2020 to holders of record at the close of business on September 1, 2020.Investor and Media Inquiries: Leo Villegas, Senior Manager, Investor Relations403-513-7817Kim Guttormson,...

Plug Power to Announce 2020 Second Quarter Results

Written by Customer Service on July 30, 2020. Posted in Public Companies.

LATHAM, N.Y., July 30, 2020 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ:PLUG), a leading provider of zero emission hydrogen engines and fueling solutions enabling e-mobility, will announce 2020 second quarter results on August 6, 2020.In conjunction with the issued results, the Company will host a live conference call and webcast.Join the call:Date: Thursday, August 6, 2020Time: 10:00 am ETParticipant Dial-In: 877-405-1239 / 201-389-0851Direct webcast: https://event.webcasts.com/starthere.jsp?ei=1351078&tp_key=c7fe17e5faThe webcast can also be accessed at www.plugpower.com, selecting the conference call link on the home page. A playback of the call will be available online for a period following the event.About Plug Power Inc.Plug Power is building the hydrogen economy as the leading provider of comprehensive hydrogen fuel cell...

Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update

Written by Customer Service on July 30, 2020. Posted in Public Companies.

THE WOODLANDS, Texas, July 30, 2020 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results and provided a business update for the three months ended June 30, 2020.“We achieved 21% growth in XERMELO net sales in the U.S. for the second quarter of 2020 compared to the prior-year period, underscoring the importance of our product to patients,” said Lonnel Coats, Lexicon’s president and chief executive officer. “In these unprecedented times of the COVID-19 pandemic, I am proud of the commitment and dedication of our employees to our mission to pioneer medicines to transform patients’ lives. We continue to make progress on our pipeline with initiation of screening of patients in the Phase 2 RELIEF-DPN-1 study for LX9211 in patients with diabetic peripheral neuropathic pain. We look forward to...

Ultralife Corporation Reports Second Quarter Results

Written by Customer Service on July 30, 2020. Posted in Public Companies.

NEWARK, N.Y., July 30, 2020 (GLOBE NEWSWIRE) — Ultralife Corporation (NASDAQ: ULBI) reported operating income of $2.3 million on revenue of $28.6 million for the second quarter ended June 30, 2020. For the second quarter of 2019, the Company reported operating income of $3.0 million on revenue of $29.4 million.“Ultralife’s second quarter adjusted earnings per share of $0.13 cents reflects the benefits of our end-market diversity and resilient business model in the face of continued business disruptions caused by the pandemic,” said Michael D. Popielec, President and Chief Executive Officer. “Our Battery and Energy Products’ medical sales and government/defense sales increased 72% and 50% year over year, respectively, and when combined with the contribution from SWE, nearly offset Communications Systems sales which were lower due...

Axsome Therapeutics to Report Second Quarter 2020 Financial Results on August 10, 2020

Written by Customer Service on July 30, 2020. Posted in Public Companies.

Axsome to host conference call and webcast on Monday, August 10, 2020 at 8:00 AM Eastern TimeNEW YORK, July 30, 2020 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today announced that it will report its financial results for the second quarter of 2020 on Monday, August 10, 2020 before the opening of the U.S. financial markets. Axsome’s management team will host a conference call at 8:00 AM Eastern Time on August 10, 2020 to discuss these results and provide a business update.To participate in the live conference call, please dial (844) 698-4029 (toll-free domestic) or (647) 253-8660 (international), and use the conference ID 4876676. A live webcast of the conference call can be accessed on the “Webcasts...

Day: July 30, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals